CAPPELLI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 15.942
EU - Europa 13.861
AS - Asia 7.388
SA - Sud America 1.234
Continente sconosciuto - Info sul continente non disponibili 331
AF - Africa 310
OC - Oceania 21
Totale 39.087
Nazione #
US - Stati Uniti d'America 15.659
GB - Regno Unito 2.951
IT - Italia 2.592
CN - Cina 2.569
RU - Federazione Russa 2.347
SG - Singapore 2.090
IE - Irlanda 1.518
DE - Germania 1.058
BR - Brasile 982
SE - Svezia 900
UA - Ucraina 837
VN - Vietnam 785
FR - Francia 732
HK - Hong Kong 679
FI - Finlandia 407
KR - Corea 377
IN - India 251
CA - Canada 138
ZA - Sudafrica 138
ES - Italia 128
TR - Turchia 118
BD - Bangladesh 116
AR - Argentina 83
MX - Messico 81
NL - Olanda 67
IQ - Iraq 65
PL - Polonia 56
JP - Giappone 53
CO - Colombia 42
ID - Indonesia 42
BE - Belgio 41
CZ - Repubblica Ceca 41
AT - Austria 40
EC - Ecuador 38
CI - Costa d'Avorio 34
RO - Romania 32
NG - Nigeria 31
KE - Kenya 27
CL - Cile 26
PK - Pakistan 25
VE - Venezuela 25
SA - Arabia Saudita 22
AE - Emirati Arabi Uniti 19
IR - Iran 19
NP - Nepal 19
MA - Marocco 18
PH - Filippine 18
EG - Egitto 17
LT - Lituania 17
AU - Australia 16
AZ - Azerbaigian 15
CH - Svizzera 15
UY - Uruguay 15
UZ - Uzbekistan 15
CR - Costa Rica 14
JO - Giordania 13
PE - Perù 11
PT - Portogallo 11
TH - Thailandia 11
PY - Paraguay 10
DZ - Algeria 9
EE - Estonia 9
EU - Europa 9
GR - Grecia 9
MY - Malesia 9
IL - Israele 8
TN - Tunisia 8
AL - Albania 7
DO - Repubblica Dominicana 7
KZ - Kazakistan 7
OM - Oman 7
BG - Bulgaria 6
ET - Etiopia 6
HU - Ungheria 6
JM - Giamaica 6
LK - Sri Lanka 6
NI - Nicaragua 6
RS - Serbia 6
BB - Barbados 5
DK - Danimarca 5
HN - Honduras 5
NZ - Nuova Zelanda 5
PA - Panama 5
SN - Senegal 5
GT - Guatemala 4
HR - Croazia 4
KG - Kirghizistan 4
MD - Moldavia 4
PS - Palestinian Territory 4
AO - Angola 3
BH - Bahrain 3
BY - Bielorussia 3
GE - Georgia 3
GH - Ghana 3
MU - Mauritius 3
NO - Norvegia 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BS - Bahamas 2
KH - Cambogia 2
Totale 38.727
Città #
Southend 2.564
Dallas 1.855
Fairfield 1.564
Dublin 1.509
Singapore 1.210
Ashburn 1.163
Chandler 780
Santa Clara 764
San Jose 754
Woodbridge 714
Jacksonville 692
Moscow 666
Wilmington 631
Milan 597
Beijing 595
Seattle 590
Hong Kong 579
Siena 573
Houston 560
Cambridge 500
Hefei 491
Ann Arbor 400
Seoul 373
Council Bluffs 346
Munich 314
Princeton 281
Ho Chi Minh City 248
Los Angeles 245
Nanjing 243
Helsinki 233
Rome 200
Hanoi 198
Lauterbourg 182
The Dalles 176
New York 172
Florence 168
Boardman 140
Fremont 127
Johannesburg 116
Shanghai 111
São Paulo 100
Bengaluru 97
Buffalo 95
San Diego 95
Dearborn 90
Menlo Park 82
Nanchang 78
Shenyang 75
Izmir 68
London 68
Málaga 64
Orem 62
Columbus 58
San Mateo 58
Lancaster 57
Frankfurt am Main 51
Tianjin 47
Chicago 46
Hebei 44
Washington 44
Düsseldorf 42
Turin 42
Montreal 41
Tokyo 41
Brussels 39
Changsha 39
Dong Ket 39
Jinan 39
Brooklyn 38
Norwalk 38
Figino 37
Stockholm 37
Amsterdam 35
Jiaxing 35
Abidjan 34
San Francisco 34
Toronto 34
Atlanta 33
Warsaw 32
Haiphong 31
Naples 31
Mexico City 30
Philadelphia 30
Redwood City 30
Vienna 30
Brno 29
Rio de Janeiro 29
Turku 29
Eboli 28
Phoenix 28
Da Nang 27
Mumbai 27
Zhengzhou 27
Chennai 26
Guangzhou 26
Redondo Beach 26
Belo Horizonte 25
Kunming 25
Baghdad 24
Abuja 23
Totale 26.293
Nome #
1,5-Diarylpyrrole-3-acetic Acids and Esters as Novel Classes of Potent and Highly Selective Cyclooxygenase-2 Inhibitors 551
Covalent hyaluronic-based coating of magnetite nanoparticles: Preparation, physicochemical and biological characterization 445
Development of Potent Inhibitors of the Mycobacterium tuberculosis Virulence Factor Zmp1 and Evaluation of Their Effect on Mycobacterial Survival inside Macrophages 403
Design, Synthesis, and Biological Evaluation of Imidazo[1,5-a]quinoline as Highly Potent Ligands of Central Benzodiazepine Receptors 402
Anionic Polymerization of a Benzofulvene Monomer Leading to a Thermoreversible π-Stacked Polymer. Studies in Macromolecular and Aggregate Structure 360
Synthesis and biological evaluation of a new class of benzothiazines as neuroprotective agents 355
A Click Chemistry-Based “Grafting Through” Approach to the Synthesis of a Biorelevant Polymer Brush 351
Novel analgesic/anti-inflammatory agents: 1,5-Diarylpyrrole nitrooxyethyl sulfides and related compounds as Cyclooxygenase-2 inhibitors containing a nitric oxide donor moiety endowed with vasorelaxant properties 342
Aromatase and 5-alpha reductase gene expression: modulation by pain and morphine treatment in male rats 337
Synthesis and Biological Evaluation of Novel Neuroprotective Pyridazine Derivatives as Excitatory Amino Acid Transporter 2 (EAAT2) Activators 336
A Nanocomposite Material Formed by Benzofulvene Polymer Nanoparticles Loaded with a Potent 5-HT3 Receptor Antagonist (CR3124) 330
Densely PEGylated polybenzofulvene brushes for potential applications in drug encapsulation 329
Structural manipulation of the conjugated phenyl moiety in 3-phenylbenzofulvene monomers: Effects on spontaneous polymerization 316
Hyaluronan-based graft copolymers bearing aggregation-induced emission fluorogens 314
Carborane-Conjugated 2-Quinolinecarboxamide Ligands of the Translocator Protein for Boron Neutron Capture Therapy 313
Electrochemical and optoelectronic properties of terthiophene- and bithiophene-based polybenzofulvene derivatives 309
A stereoselective approach to peptidomimetic BACE1 inhibitors 304
Nanoreactors for the multi-functionalization of poly-histidine fragments 304
A Non-Peptide NK1 Receptor Agonist Showing Subpicomolar Affinity 301
Bithiophene-based polybenzofulvene derivatives with high stacking and hole mobility 299
Development of subnanomolar-affinity serotonin 5-HT4 receptor ligands based on quinoline structures 299
Synthesis, biological evaluation and molecular modeling of novel selective COX-2 inhibitors: sulfide, sulfoxide, and sulfone derivatives of 1,5-diarylpyrrol-3-substituted scaffold 297
Xanthopsin-like systems via site-specific click-functionalization of a retinoic acid binding protein 287
Design and development of hyaluronan-functionalized polybenzofulvene nanoparticles as CD44 receptor mediated drug delivery system 285
Poly-histidine grafting leading to fishbone-like architectures 284
Design, synthesis and biological evaluation of light-driven on-off multitarget AChE and MAO-B inhibitors 282
Hyaluronan-coated polybenzofulvene brushes as biomimetic materials 282
Exploring Translocator Protein (TSPO) Medicinal Chemistry: An Approach for Targeting Radionuclides and Boron Atoms to Mitochondria 280
Combining Spontaneous Polymerization and Click Reactions for the Synthesis of Polymer Brushes: A “Grafting Onto” Approach 277
Bivalent Ligands for the Serotonin 5-HT3 Receptor 275
Polybenzofulvene Derivatives Bearing Dynamic Binding Sites as Potential Anticancer Drug Delivery Systems 275
Synthesis and biological evaluation of fluorinated 1,5-diarylpyrrole-3-alkoxyethyl ether derivatives as selective COX-2 inhibitors endowed with anti-inflammatory activity 275
Design, Synthesis, and Dynamics of a Green Fluorescent Protein Fluorophore Mimic with an Ultrafast Switching Function 274
Design, Synthesis and Characterization of a Visible-Light-Sensitive Molecular Switch and Its PEGylation Towards a Self-Assembling Molecule 271
Characterization of Quinoline Derivatives. II. 7-(4-methyl-1-piperazinyl)-6H-[1]benzopyrano[3,4-c]quinoline 269
Click-Chemistry Cross-Linking of Hyaluronan Graft Copolymers 268
Multivalent ligands for the serotonin 5-HT4 receptor 264
Cyclodextrin-Adamantane Host–Guest Interactions on the Surface of Biocompatible Adamantyl-Modified Glycodendrimers 258
3-Substituted-1,5-diarly-2-alkyl-pyrroles Highly Selective and Orally Effective COX-2 Inhibitors 258
Characterization of persistent intramolecular C-H⋅⋅⋅X(N,O) bonds in solid state and solution 257
Antiproliferative effect of two novel COX-2 inhibitors on human keratinocytes 257
Synthesis and structure-activity relationship studies in serotonin 5-HT4 receptor ligands based on a benzo[de][2,6]naphthridine scaffold 256
Synthesis and structure–activity relationship studies in serotonin 5-HT1A receptor agonists based on fused pyrrolidone scaffolds 255
5-HT and Benzodiazepine Receptor Ligands. III. Synthesis and Receptor Affinities of 1,2,4,-Triazolo[4',3':1,6]pyridazino[4,5-b]quinoline and 2,3-Dihydro-9-phenyl-1H-pyrrolo[3,4-b]quinoline-1-one Derivatives 254
Synthesis and Spontaneous Polymerization of Oligo(ethylene glycol)-Conjugated Benzofulvene Macromonomers. A Polymer Brush Forming a Physical Hydrogel 254
Design, Synthesis, and Biological Evaluation of AT1 Angiotensin II Receptor Antagonists Based on the Pyrazolo[3,4-b]pyridine and related Heteroaromatic Bicyclic Systems 253
Novel Analgesic/Anti-inflammatory Agents: 1,5-Diarylpyrrole Nitrooxyalkyl Ethers and Related Compounds as Cyclooxygenase-2 Inhibiting Nitric Oxide Donors 252
6-(1-Piperazinyl)-7H-indeno[2,1-c]quinoline Derivatives with High Affinity and Selectivity for 5-HT3 Serotonin Sites 251
Aggregation-Induced Förster Resonance Energy Transfer in Polybenzofulvene/Dye Nanoparticles 251
Development of Imidazole-Reactive Molecules Leading to a New Aggregation-Induced Emission Fluorophore Based on the Cinnamic Scaffold 251
A Facile Access to Green Fluorescent Albumin Derivatives 246
The novel anti-inflammatory agent VA694, endowed with both NO-releasing and COX2-selective inhibiting properties, exhibits NO-mediated positive effects on blood pressure, coronary flow and endothelium in an experimental model of hypertension and endothelial dysfunction 245
Wound healing properties of hyaluronan derivatives bearing ferulate residues 245
Dendrimeric tetravalent ligands for the serotonin-gated ion channel 244
Amidine, Thiourea and Guanidine Derivatives of 2-Aminobenzothiazoles and Aminobenzothiazines, Novel Pharmacological Agents for the Treatment of Neurodegenerative Pathologies 244
Red and deep-red emissive polymeric nanoparticles based on polybenzofulvene and perylenediimide derivatives 242
The Interactions of the 5-HT3 Receptor with Quipazine-Like Arylpiperazine Ligands. The Journey Track at the End of the First Decade of the Third Millennium 241
Design, Synthesis, and Preliminary Biological Evaluation of Pyrrolo[3,4-c]quinolin-1-one and Oxoisoindoline Derivatives as Aggrecanase Inhibitors 240
A Computational Model of the 5-HT3 Receptor Extracellular Domain: Search for Ligand Binding Sites 239
π-Stacked polybenzofulvene derivatives as hosts for yellow and red emitting OLEDs 238
Characterization of Quinoline Derivatives. I. 6,7-Dihydro-8-(4-methyl-1-piperazinyl)[1]benzoxepino[4,5-c]quinoline 0.13-Hydrate 233
Design, Synthesis, and Structure-Affinity Relationship Studies in NK1 Receptor Ligands Based on Azole-Fused Quinolinecarboxamide Moieties 232
Physicochemical and biopharmaceutical characterization of endo-2-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-2,3-dihydro-1H-benz[e]isoindol-1-one (CR3124) a novel potent 5-HT3 receptor antagonist 231
A tri(ethylene glycol)-tethered Morita-Baylis-Hillman dimer in the formation of macrocyclic crown ether-paracyclophane hybrid structures 229
Bile Acid Binding Protein Functionalization Leads to a Fully Synthetic Rhodopsin Mimic 228
Structural Manipulation of Benzofulvene Derivatives Showing Spontaneous Thermoreversible Polymerization. Role of the Substituents in the Modulation of Polymer Properties 227
11C-Labelling of the 5-HT3 Antagonist VC125 for PET Distribution Studies 226
Phenylindenone isomers as divergent modulators of p38α MAP kinase 222
Structural characterization of a synthetic mimic of the Photoactive Yellow Protein 222
Design, synthesis, structure, and photophysical features of highly emissive cinnamic derivatives 222
Novel multitarget directed ligands inspired by riluzole: A serendipitous synthesis of substituted benzo[b][1,4]thiazepines potentially useful as neuroprotective agents 219
Enlarging the NSAIDs Family: Ether, Ester and Acid Derivatives of the 1,5-Diarrylpyrrole Scaffold as novel anti-inflammatory and analgesic agents 218
Physicochemical properties of a new PEGylated polybenzofulvene brush for drug encapsulation 218
Functionalization of protein hexahistidine tags by functional nanoreactors 216
Light-mediated activation/deactivation control and in vitro ADME-Tox profiling of a donepezil-like Dual AChE/MAO-B Inhibitor 215
Highly emissive supramolecular assemblies based on π-stacked polybenzofulvene hosts and a benzothiadiazole guest 215
Synthesis and characterization of charge-transporting π-stacked polybenzofulvene derivatives 213
Antiamnestic Effect of the Two Novel k-Opioid Agonists, VA-100 and VA-101, in the Mouse Passive Avoidance Test 210
Synthesis and Structure-Activity Relationship Studies in Translocator Protein Ligands Based on a Pyrazolo[3,4-b]quinoline Scaffold 210
Side chain engineering in π-stacked polybenzofulvene derivatives bearing electron-rich chromophores for OLED applications 209
Synthesis of 2-Substituted-2,3-dihydro-9-phenyl-1H-pyrrolo[3,4-b]quinolin-3-ones as Potential Peripheral Benzodiazepine-receptor Ligands 206
Synthesis and biological evaluation of amidine, guanidine, and thiourea derivatives of 2-amino(6-trifluoromethoxy)benzothiazole as neuroprotective agents potentially useful in brain diseases 206
Mapping the Peripheral Benzodiazepine Receptor Binding Site by Conformationally Restrained Derivatives of 1-(2-Chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide (PK11195) 204
Polybenzofulvenes-based blends with benzothiadiazole and perylene diimide derivatives emitting from yellow to the deep-red by resonant energy transfer processes 204
Synthesis of 6,7-Dihydro-8-(4-methyl-1-piperazinyl)-[1]benzoxepino[4,5-c]quinoline as Potential 5-HT3 Receptor Ligand 203
Non-peptide NK1 receptor ligands based on the 4-phenylpyridine moiety 202
Structural characterization of a synthetic mimic of the Photoactive Yellow Protein 202
Cyclooxygenase-2 Inhibitors. 1,5-Diarylpyrrol-3-acetic Esters with Enhanced Inhibitory Activity Toward Cyclooxygenase-2 and Improved Cyclooxygenase-2/Cyclooxygenase-1 Selectivity 201
Synthesis of 6-(4-Methyl-1-piperazinyl)-7H-indeno[2,1-c]quinoline Derivatives as Potential 5-HT Receptor Ligands 200
Synthesis, Labeling, and Biological Evaluation of Halogenated 2-Quinolinecarboxamides as Potential Radioligands for the Visualization of Peripheral Benzodiazepine Receptors 200
Reversible polymerization techniques leading to π-stacked polymers 200
Synthesis, Biological Evaluation, and Quantitative Receptor Docking Simulations of 2-Acylaminoethyl-1,4-benzodiazepines as novel Tifluadom-Like Ligands with High Affinity and Selectivity for k-Opioid Receptors 199
Novel and Highly Potent 5-HT3 Receptor Agonists Based on a Pyrroloquinoxaline Structure 198
Mapping and Fitting the Peripheral Benzodiazepine Receptor Binding Site by Carboxamide Derivatives. Comparison of Different Approaches to Quantitative Ligand-Receptor Interaction Modeling 198
Novel Basic Derivatives of Benz[e]isoindol-1-ones and Pyrrolo[3,4-c]quinolin-1-ones with 5-HT3 Antagonistic Activity, their Preparation and their Therapeutic Use 197
In Vitro Effects of VA441, a New Selective Cyclooxygenase-2 Inhibitor, on Human Osteoarthritic Chondrocytes exposed to IL-1β 196
Structure-Property Relationships in Densely Grafted π-Stacked Polymers 195
Molecular Basis of Peripheral vs Central Benzodiazepine Receptor Selectivity in a New Class of Peripheral Benzodiazepine Receptor Ligands Related to Alpidem 195
Synthesis, Biological Evaluation, and Enzyme Docking Simulations of 1,5-Diarylpyrrole-3-Alkoxyethyl Ethers as Selective Cyclooxygenase-2 Inhibitors Endowed with Anti-inflammatory and Antinociceptive Activity 194
Structure-Activity Relationships in Carboxamide Derivatives Based on the Targeted Delivery of Radionuclides and Boron Atoms by Means of Peripheral Benzodiazepine Receptor Ligands 194
Totale 25.885
Categoria #
all - tutte 116.444
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 116.444


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.848 0 0 128 300 80 66 126 84 101 296 245 422
2022/20233.093 177 241 406 434 306 615 93 254 291 96 110 70
2023/20242.567 93 50 276 106 109 644 858 79 12 44 59 237
2024/20255.214 93 225 465 292 623 292 211 339 433 234 567 1.440
2025/202612.428 924 1.778 1.579 1.477 2.220 398 1.427 321 463 651 264 926
2026/20271.360 509 366 485 0 0 0 0 0 0 0 0 0
Totale 39.087